REDUCEDT+7
Arbutus Biopharma Corp · NASDAQ
−48,081 sh · $240.4K
Filed 7 Oct 2026SEC Form 4view source
- REDUCEDT+30
Arbutus Biopharma Corp · NASDAQ
−206,637 sh · $1.0M
Filed 23 Sept 2026SEC Form 4view source - ACQUIREDT+30
Arbutus Biopharma Corp · NASDAQ
+265,625 sh · $927.0K
Filed 23 Sept 2026SEC Form 4view source - ACQUIREDT+30
Arbutus Biopharma Corp · NASDAQ
+27,475 sh · $120.6K
Filed 23 Sept 2026SEC Form 4view source